SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-16-000198
Filing Date
2016-11-14
Accepted
2016-11-14 17:31:07
Documents
67
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-093016x10q.htm 10-Q 1147836
2 EXHIBIT 10.10 elevenbioterminationagt.htm EX-10.10 19120
3 EXHIBIT 31.1 ebio-093016x311.htm EX-31.1 12086
4 EXHIBIT 31.2 ebio-093016x312.htm EX-31.2 11952
5 EXHIBIT 32.1 ebio-093016x321.htm EX-32.1 7024
12 ebiolandlordsignature.jpg GRAPHIC 41904
13 ebiotenantsignaturea01.jpg GRAPHIC 28890
14 elevenbioterminationa_image1.jpg GRAPHIC 69740
  Complete submission text file 0001485003-16-000198.txt   5259602

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ebio-20160930.xml EX-101.INS 819371
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20160930.xsd EX-101.SCH 46665
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20160930_cal.xml EX-101.CAL 62028
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20160930_def.xml EX-101.DEF 208012
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20160930_lab.xml EX-101.LAB 564237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20160930_pre.xml EX-101.PRE 339987
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 161996180
SIC: 2834 Pharmaceutical Preparations